These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32627118)

  • 21. Prognostic Value of Mismatch Repair Genes for Patients With Colorectal Cancer: Meta-Analysis.
    Hou JT; Zhao LN; Zhang DJ; Lv DY; He WL; Chen B; Li HB; Li PR; Chen LZ; Chen XL
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818808507. PubMed ID: 30411662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ⅰ.Diagnosis and Treatment of MSI-H/dMMR Colorectal Cancer].
    Nakazawa T; Bando H
    Gan To Kagaku Ryoho; 2020 Nov; 47(11):1559-1564. PubMed ID: 33268728
    [No Abstract]   [Full Text] [Related]  

  • 24. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
    Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
    Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medullary colorectal carcinoma. Do we really know it?
    Puerta Vicente A; Vilar Tabanera A; García Pérez JC
    Rev Esp Enferm Dig; 2020 Jul; 112(7):579-580. PubMed ID: 32579007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low intensity treatment in metastatic colorectal cancer.
    Wong HL; Tie J
    Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):97-99. PubMed ID: 36470292
    [No Abstract]   [Full Text] [Related]  

  • 28. Histologic Features Do Not Reliably Predict Mismatch Repair Protein Deficiency in Colorectal Carcinoma: The Results of a 5-Year Prospective Evaluation.
    Olevian DC; Pai RK
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):231-238. PubMed ID: 29189259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.
    de Rosa N; Rodriguez-Bigas MA; Chang GJ; Veerapong J; Borras E; Krishnan S; Bednarski B; Messick CA; Skibber JM; Feig BW; Lynch PM; Vilar E; You YN
    J Clin Oncol; 2016 Sep; 34(25):3039-46. PubMed ID: 27432916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 32. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.
    Joshi AD; Corral R; Siegmund KD; Haile RW; Le Marchand L; Martínez ME; Ahnen DJ; Sandler RS; Lance P; Stern MC
    Carcinogenesis; 2009 Mar; 30(3):472-9. PubMed ID: 19029193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer.
    Creasy JM; D'Angelica MI
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):747-748. PubMed ID: 30334194
    [No Abstract]   [Full Text] [Related]  

  • 34. Thinking outside the box: a more efficient diagnostic approach in metastatic colorectal cancer.
    Schreyer AG
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):494-495. PubMed ID: 31080094
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASO Author Reflections: Hepatectomy and Proctectomy for Metastatic Rectal Cancer: Is a Combined Approach Best for All Patients?
    Concors SJ; Roses RE; Paulson EC
    Ann Surg Oncol; 2019 Nov; 26(12):3980-3981. PubMed ID: 31359274
    [No Abstract]   [Full Text] [Related]  

  • 37. Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management.
    Overman MJ; Ernstoff MS; Morse MA
    Am Soc Clin Oncol Educ Book; 2018 May; 38():239-247. PubMed ID: 30231358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer.
    Passot G; Vauthey JN; Chun YS
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):850-851. PubMed ID: 30421059
    [No Abstract]   [Full Text] [Related]  

  • 39. Who Should Undergo Transplant for Metastatic Colorectal Cancer?: A Shift in Treatment Paradigm.
    Fong Y
    JAMA Surg; 2021 Jun; 156(6):557. PubMed ID: 33787867
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?
    Germini DE; Mader AM; Gomes LG; Teodoro TR; Franco MI; Waisberg J
    Tumour Biol; 2016 Feb; 37(2):2757-64. PubMed ID: 26408182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.